Results 41 to 50 of about 36,170 (217)

Hormone replacement therapy [PDF]

open access: yes, 2012
Martha Hickey, Jane Elliott, Sonia Louise ...
Davison, S., Elliott, C., Hickey, M.
core   +2 more sources

A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2022
Testing for polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene is still a standard part of thrombophilia testing in many laboratories. However, it is clear that these polymorphisms are not risk factors for arterial or venous thrombosis
Thomas G. Deloughery   +4 more
doaj   +1 more source

The Central role of KNG1 gene as a genetic determinant of coagulation pathway-related traits: Exploring metaphenotypes [PDF]

open access: yes, 2016
Traditional genetic studies of single traits may be unable to detect the pleiotropic effects involved in complex diseases. To detect the correlation that exists between several phenotypes involved in the same biological process, we introduce ...
Brunel, Helena   +7 more
core   +4 more sources

A clinical audit of thrombophilia testing in pediatric patients with acute thromboembolic events: impact on management

open access: yesBlood Advances, 2017
: Routine testing for inherited and acquired thrombophilia defects is frequently performed in pediatric patients with thromboembolic events (TEEs). No consensus guidelines exist regarding the timing of testing or the type of patients to be tested.
Chakri Gavva   +2 more
doaj   +1 more source

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma. [PDF]

open access: yes, 2018
It is common knowledge that cancer patients are more prone to develop venous thromboembolic complications (VTE). It is therefore not surprising that patients with hepatocellular carcinoma (HCC) present with a significant risk of VTE, with the portal vein
Burra, P   +5 more
core   +1 more source

Hereditary thrombophilia.

open access: yesThrombosis journal, 2006
Thrombophilia can be defined as a predisposition to form clots inappropriately. Thrombotic events during infancy and childhood are increasingly recognized as a significant source of mortality and morbidity. The predisposition to form clots can arise from genetic factors, acquired changes in the clotting mechanism, or, more commonly, an interaction ...
Dickerman Joseph D, Khan Salwa
openaire   +3 more sources

The 3’ End Prothrombin Gene Variants in Serbian Patients with Idiopathic Thrombophilia

open access: yesBalkan Journal of Medical Genetics, 2014
Thrombophilia is a multifactorial disorder that arises from the interaction of acquired and genetic risk factors. Despite the significant efforts made to understand the etiology of this disease, there are still a certain number of patients suffering from
Aradjanski M.   +6 more
doaj   +1 more source

Inherited thrombophilia and reproductive disorders [PDF]

open access: yes, 2018
K
Csorba, Roland   +5 more
core   +1 more source

Whole-exome sequencing in evaluation of patients with venous thromboembolism

open access: yesBlood Advances, 2017
: Genetics play a significant role in venous thromboembolism (VTE), yet current clinical laboratory-based testing identifies a known heritable thrombophilia (factor V Leiden, prothrombin gene mutation G20210A, or a deficiency of protein C, protein S, or ...
Eun-Ju Lee   +25 more
doaj   +1 more source

Living with a long-term condition: understanding well-being for individuals with thrombophilia or asthma [PDF]

open access: yes, 2016
range of literature has explored the experience of living with a long-term condition (LTC), and frequently treats such experiences and conditions as problematic.
Afrell M.   +21 more
core   +4 more sources

Home - About - Disclaimer - Privacy